Balanced news tone
News Sentiment
AZN sentiment intelligence
AstraZeneca PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
36 relevant articles
News tone and price action are not far from neutral.
89/100 classification confidence.
directly relevant articles
high-authority source matches
-1.7% over one week, -4.9% over four weeks, trend inactive, and near fair-value range.
Why AstraZeneca (LSE:AZN) Is Reframing Blue-Chip Stocks
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
89/100 classification
One-week reaction
-1.7%
Price digesting
Trend fit
Trend inactive
-4.9% over four weeks
Fair value
12.5%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
24
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Pharmaceutical Executive
Direct company coverage
AstraZeneca Stock Becomes UK’s Biggest Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Nov 2025 08:00
- Source
- Pharmaceutical Executive
Reuters
Direct company coverage
FTSE 100 closes at record high on rate cut bets; AstraZeneca shines
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Nov 2025 08:00
- Source
- Reuters
The Guardian
Direct company coverage
AstraZeneca to upgrade US listing in ‘knock-back for London’
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 29 Sep 2025 07:00
- Source
- The Guardian
Sky News
Direct company coverage
'Knock-back for London' as AstraZeneca sells shares directly on rival New York Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Sep 2025 07:00
- Source
- Sky News
AstraZeneca
Direct company coverage
AstraZeneca to harmonise its listing structure across the London Stock Exchange, Nasdaq Stockholm and New York Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Sep 2025 07:00
- Source
- AstraZeneca
Market source
Direct company coverage
AstraZeneca to overhaul US listing but remain on London market and keep UK HQ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Sep 2025 07:00
- Source
- Market source